We are live on
!
Find out more
HCM
Hoplite Capital Management Portfolio holdings
AUM
$15.1M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.1%
1 Year Est. Return
-27.41%
3 Year Est. Return
+32.9%
5 Year Est. Return
+85.27%
10 Year Est. Return
–
AUM
$3.61B
AUM Growth
-$309M
(-7.9%)
Cap. Flow
-$583M
Cap. Flow
% of AUM
-16.13%
Top 10 Holdings %
Top 10 Hldgs %
51.65%
Holding
42
New
5
Increased
8
Reduced
5
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$139M |
| 2 |
AbbVie
ABBV
|
+$106M |
| 3 |
SGI
Somnigroup International
SGI
|
+$91.9M |
| 4 |
Air Products & Chemicals
APD
|
+$83.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$68.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$173M |
| 2 |
Adobe
ADBE
|
+$138M |
| 3 |
Applied Materials
AMAT
|
+$122M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$120M |
| 5 |
Netflix
NFLX
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.33% |
| 2 | Consumer Discretionary | 31.73% |
| 3 | Communication Services | 13.05% |
| 4 | Consumer Staples | 5.79% |
| 5 | Technology | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEE
1
DELISTED
Sealed Air
SEE
| $262M | 7.27% |
6,184,327
+1,454,533
| +31% | +$54.7M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $247M | 6.83% |
958,331
| – | – |
|
3
Bausch Health
BHC
$1.65B
| $197M | 5.44% |
1,373,429
| – | – |
|
|
4
AbbVie
ABBV
$458B
| $189M | 5.23% |
2,884,837
+1,681,079
| +140% | +$106M |
|
5
Sinclair Inc
SBGI
$974M
| $176M | 4.87% |
6,422,998
| – | – |
|
|
WBA
6
DELISTED
Walgreens Boots Alliance
WBA
| $174M | 4.82% |
2,286,188
-516,443
| -18% | -$34.5M |
|
7
Graphic Packaging
GPK
$3.26B
| $165M | 4.58% |
12,145,522
+909,019
| +8% | +$11.3M |
|
|
SUNE
8
DELISTED
SUNEDISON, INC COM
SUNE
| $160M | 4.44% |
8,212,658
+1,999,291
| +32% | +$38M |
|
|
GRA
9
DELISTED
W.R. Grace & Co.
GRA
| $155M | 4.29% |
1,623,853
+185,247
| +13% | +$17.2M |
|
10
Constellation Brands
STZ
$22.2B
| $140M | 3.88% |
1,427,011
+192,682
| +16% | +$17.6M |
|
|
11
Baidu
BIDU
$35.8B
| $139M | 3.84% |
+607,644
| New | +$139M |
|
12
Bath & Body Works
BBWI
$4.01B
| $135M | 3.74% |
1,932,104
| – | – |
|
13
H&R Block
HRB
$5.18B
| $123M | 3.41% |
3,658,459
| – | – |
|
14
Jazz Pharmaceuticals
JAZZ
$15.9B
| $121M | 3.36% |
741,940
+104,232
| +16% | +$17.3M |
|
|
OPLN
15
Openlane
OPLN
$4.17B
| $117M | 3.23% |
8,884,171
| – | – |
|
16
Meta Platforms (Facebook)
META
$1.51T
| $109M | 3.01% |
1,394,473
| – | – |
|
17
JD.com
JD
$40.8B
| $95.9M | 2.66% |
4,145,244
+989,596
| +31% | +$24.4M |
|
18
Abbott
ABT
$180B
| $94.1M | 2.61% |
2,090,063
| – | – |
|
|
SGI
19
Somnigroup International
SGI
$15.1B
| $92.4M | 2.56% |
+6,730,628
| New | +$91.9M |
|
|
20
Air Products & Chemicals
APD
$66.3B
| $87.9M | 2.43% |
+658,774
| New | +$83.3M |
|
|
QLIK
21
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $80.5M | 2.23% |
2,605,100
| – | – |
|
22
Cencora
COR
$60.3B
| $74.2M | 2.05% |
822,956
-673,445
| -45% | -$57.7M |
|
|
23
Vertex Pharmaceuticals
VRTX
$121B
| $72.1M | 2% |
+606,555
| New | +$68.3M |
|
|
AGN
24
DELISTED
Allergan Inc
AGN
| $71.6M | 1.98% |
336,960
-316,478
| -48% | -$62.9M |
|
|
WCG
25
DELISTED
Wellcare Health Plans, Inc.
WCG
| $70.6M | 1.96% |
860,627
| – | – |
|
Similar funds
PCP
DCM
FCM
RGNCM
ICP
PVAM
CIM
LAM
Hoplite Capital Management's Q4 2014 Portfolio in Review
As of Q4 2014, Hoplite Capital Management held 42 positions worth $3.61B, down 7.9% from $3.92B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Hoplite Capital Management withdrew a net $583M in Q4 2014, closing 11 positions and reducing 5 holdings. Its most notable exit was Alibaba, an estimated $173M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Hoplite Capital Management opened a new position in Baidu worth $139M.
- Hoplite Capital Management's largest Q4 2014 buy was Baidu: 607,644 shares worth $139M.
- Hoplite Capital Management added most to AbbVie in Q4 2014, an estimated $106M increase.
- Hoplite Capital Management's biggest Q4 2014 reduction was Allergan Inc, cutting an estimated $62.9M.
- Hoplite Capital Management fully exited Alibaba in Q4 2014, selling an estimated $173M.
- Hoplite Capital Management's ten largest holdings make up 52% of its $3.61B portfolio in Q4 2014.
- Hoplite Capital Management opened 5 new positions and closed 11 in Q4 2014.
- Hoplite Capital Management's portfolio value fell 7.9% quarter-over-quarter to $3.61B.
Based on Hoplite Capital Management's 13F filing for Q4 2014, filed 13 Feb 2015.